Product Information
AUROVELA 21 1.5-30 TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.3556 per EA under NDC 65862093574. Its NADAC has been published 365 times since Jul 3, 2019.
Strength
30; 1.5 ug/1; mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862093574
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ETHINYL ESTRADIOL; NORETHINDRONE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA207581On Market Since
6/26/2017
Price Statistics
The NADAC for AUROVELA 21 1.5-30 TABLET has been published 365 times since Jul 3, 2019, and over the history we have for it it has declined 45.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3556 per EA |
|---|---|
| All-time high | $0.6934 (Aug 14, 2019) |
| All-time low | $0.3066 (Jul 17, 2024) |
| 52-week high | $0.4097 |
| 52-week low | $0.3344 |
| Median price | $0.5264 |
| Average price | $0.5034 |
| Largest weekly change | +67.3% (Aug 21, 2024) |
| Weeks tracked | 365 |
| Tracking since | Jul 3, 2019 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of AUROVELA 21 1.5-30 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AUROVELA 21 1.5-30 TABLET, manufactured by Aurobindo Pharma Limited, is $0.3556 per EA (NDC 65862093574), effective Jun 24, 2026.
How has the price of AUROVELA 21 1.5-30 TABLET changed over time?
Over the history we have for it, the NADAC for AUROVELA 21 1.5-30 TABLET has declined 45.9%. It has been tracked across 365 weekly CMS publications since Jul 3, 2019.
What are the highest and lowest recorded NADAC prices for AUROVELA 21 1.5-30 TABLET?
Since Jul 3, 2019, the NADAC for AUROVELA 21 1.5-30 TABLET has ranged from a low of $0.3066 (Jul 17, 2024) to a high of $0.6934 (Aug 14, 2019), with a median of $0.5264 per EA.
Are there cheaper alternatives to AUROVELA 21 1.5-30 TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as AUROVELA 21 1.5-30 TABLET, but none are currently priced below it.
Who manufactures AUROVELA 21 1.5-30 TABLET?
AUROVELA 21 1.5-30 TABLET (NDC 65862093574) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification